Research Article
A Comprehensive Prognostic and Immunological Analysis of a New Three-Gene Signature in Hepatocellular Carcinoma
Figure 6
Survival analysis of HCC patients based on the risk score and several immune checkpoint molecules. (a) Correlation analysis between risk score and several key immune-related molecules. (b–i) Two-factor survival analyses of risk score and immune checkpoint molecules including PDCD1 (b), CTLA4 (c), CD80 (d), CD86 (e), CD274 (f), PDCD1LG2 (g), CD276 (h), and VTCN1 (i).
(a) |
(b) |
(c) |
(d) |
(e) |
(f) |
(g) |
(h) |
(i) |